By Joe Paradza Allied Health Leader & Healthcare Economics Analyst Therapy Insights -Independent Australian Publication
Published: 28 March 2026

The maths appears straightforward. A GP visit costs $80 out of pocket. You don't have $80 this week. You skip it. The condition resolves, or it doesn't, and three months later you are in an emergency department, facing a bill of several thousand dollars and a health outcome significantly worse than if you had attended when the problem was manageable.

The individual calculation is well-understood in clinical terms. What is less well-understood is how this same decision, replicated across millions of households, across dozens of countries, across every tier of the income spectrum, aggregates into a global economic problem that dwarfs the short-term savings it appeared to generate.

The cost of skipping healthcare is not simply the cost borne by the individual who skipped it. It is a system-wide liability, quietly accumulating in emergency departments, inpatient wards, and late-stage treatment programs, paid ultimately by governments, insurers, employers, and communities that absorb the downstream expense of care deferred until it could no longer be deferred.

This article examines what the data says about that liability, and why the gap between the cost of early care and the cost of delayed care represents one of the most significant, and most avoidable, inefficiencies in modern health systems.

The Numbers Behind One Missed Appointment

The direct cost comparison between preventive primary care and emergency care is stark and consistent across health systems.

The average cost of an emergency room visit in the United States is $1,389, compared to $167 for a primary care physician visit. That is roughly an eightfold difference, before accounting for the higher clinical complexity, longer admission duration, and greater specialist involvement that characterise presentations driven by delayed care.

When visiting the emergency room for a condition that could have been identified and treated by a primary care doctor, it is on average 300 to 700 percent more costly. The range reflects condition severity and the extent of clinical deterioration that occurred during the period of deferral.

Research shows that nearly 30 percent of emergency room visits in the United States could have been effectively managed in a primary care setting. These unnecessary emergency presentations do not simply add to healthcare costs, they simultaneously degrade the system's capacity to manage genuinely acute conditions, prolonging wait times for everyone in the queue.

These figures are US-centric, but the underlying logic is universal. In any health system, the cost gradient between early, managed primary care and late, acute emergency care follows the same direction, and the gap widens as the duration of deferral extends. The preventative vs emergency cost differential is not a feature of any specific model of healthcare financing. It is a property of disease biology, which does not pause in the absence of intervention.

What Preventive Care Actually Saves

The economic case for preventive care is among the most consistently documented in health economics, and among the most consistently underfunded in practice.

A Deloitte analysis, drawing on a review of 100 published papers estimating the return on investment from prevention at different life stages, found that the UK has the potential to unlock £8 in socio-economic returns for every £1 spent on preventive healthcare. The returns accrue across individuals, families, healthcare systems, employers, and wider society, reflecting the fact that the cost of ill-health is not contained to the healthcare budget but ripples outward through productivity, disability, carer burden, and welfare expenditure.

Increasing prevention spend from the current 6 percent of total health expenditure to 10 percent could lead to £42 billion of savings to the UK healthcare system in ten years. That figure represents a return on investment that most infrastructure or technology programmes would struggle to match.

The OECD's most recent Health at a Glance report reinforces this framing directly. OECD Secretary-General Mathias Cormann stated: "Preventive and primary healthcare interventions can be a cost-effective way to address major risk factors for health, such as obesity, smoking, or harmful alcohol use. To enhance the effectiveness and fiscal sustainability of our healthcare systems, countries should increase the share of total health spending they allocate to these interventions, which is currently 3% for preventive healthcare and 14% for primary healthcare."

Three percent. That is the share of total OECD health expenditure currently directed toward prevention. The consequence of this structural underinvestment is measurable: primary care is helping keep people well and out of hospital, with avoidable hospital admissions falling in 28 of 30 OECD countries with available data over the last decade. The gains from existing primary care investment are real. The opportunity cost of underinvesting further is proportionally larger.

The Data on Delayed Care and System Cost

When patients skip care due to healthcare affordability impact concerns, the cost does not disappear from the system. It relocates, from the cheaper, earlier setting to the more expensive, later one.

Value-based care models reduce hospitalisations by 18 percent and lower costs by 12 percent compared to fee-for-service models, according to a Business at OECD Health Forum Synthesis Report. The corollary is equally instructive: systems that fail to invest in proactive, prevention-oriented care are effectively choosing the higher-cost model by default.

In total, there were over three million premature deaths in 2023 among people aged under 75 that could have been avoided through better prevention and healthcare interventions. These deaths represent both a human tragedy and an enormous economic loss, in productivity, in family stability, in the foregone contribution of individuals who could have been healthy, functioning members of the workforce and community with earlier intervention.

OECD public spending on health is set to grow on average by 1.5 percent of GDP by 2045 across member countries, driven largely by technological change, rising expectations, and ageing populations. As that spending grows, the allocation between prevention and acute care will become increasingly consequential. A system that continues directing only 3 percent of expenditure toward prevention will face exponentially rising acute care costs as the health burden of deferred conditions accumulates across an ageing population.

The Household Economics of Skipping Care

The decision to skip a doctor visit is rarely made abstractly. It is made in the context of rent due, groceries to buy, fuel to fill, and a household budget that has been compressed by cost-of-living pressures on multiple fronts simultaneously.

About two-thirds of US adults, 66 percent, say they worry about being able to afford healthcare expenses for themselves and their family, including 32 percent who are very worried.

Among adults under age 65, nearly one in five, 8 percent, report that their health got worse because they skipped or delayed getting care. Among uninsured adults, that figure rises to 42 percent.

The household financial calculus is made more complex by the design of insurance systems in many countries. In the United States, in 2025, the average annual deductible for employer-sponsored coverage was $1,886, with the average co-insurance rate being 20 percent for a hospital visit, and nearly half of employer-sponsored plans, 46 percent, having an out-of-pocket maximum over $5,000. For households with limited savings, these thresholds are not theoretical limits, they are cliffs.

An estimated 60 to 65 percent of personal bankruptcies in the United States are tied to unpaid medical bills. People with medical debt are five times more likely to forgo mental health care than people without medical debt.

This dynamic, where the financial consequences of one healthcare event create barriers to subsequent care, represents a compounding liability. The household that cannot absorb a $2,000 emergency bill is the same household that will be least able to afford the follow-up appointments, specialist referrals, and medication costs that flow from that initial presentation. The affordability problem does not resolve after one acute event. It frequently deepens.

The System-Level Cost of Deferred Care

At the system level, the accumulation of individual deferral decisions creates a structural burden that manifests across multiple budget lines simultaneously, not all of which are attributed to their source.

Emergency departments bear the most visible load. When primary care is inaccessible, acute presentations rise, not because more emergencies occur, but because more conditions are allowed to reach emergency status before intervention. The emergency department then absorbs the clinical complexity and cost of that progression.

Surveys consistently show that people delay or forgo care due to cost, worry about their ability to pay healthcare bills, and incur medical debt. Healthcare affordability, or a lack thereof, can harm individual health. If costs are too high, people will delay or skip care, which has significant impacts down the line on both health outcomes and cost.

The system pays for those impacts in ways that are not always traceable back to the original deferral. A hospitalisation for a diabetic complication is recorded as a diabetes admission, not as the downstream consequence of a missed GP visit three months prior. A late-stage cancer diagnosis is recorded as an oncology case, not as the result of a skipped screening when transport costs made the appointment unmanageable.

This attribution problem is part of why the cost of skipping healthcare is systematically underestimated. The savings from deferred primary care are immediate and visible in budget data. The costs are delayed, diffuse, and recorded against different line items by the time they arrive. This structural accounting gap creates persistent political incentives to underinvest in prevention and primary care, because the consequences appear elsewhere, later, and in ways that obscure their origin.

Global Healthcare Affordability: The Widening Gap

The pattern of deferred care due to cost is not confined to the United States, nor to systems with explicit gaps in coverage. It is emerging as a consistent trend across health systems of varying design, including those with universal coverage frameworks.

As documented in the global healthcare access crisis analysis, the World Health Organization and World Bank's 2025 Universal Health Coverage Monitoring Report found that 2.1 billion people worldwide experience financial hardship to access healthcare. The scale of that figure makes the aggregate economic cost of skipping care, through delayed diagnoses, avoidable hospitalisations, and preventable mortality, one of the largest untracked liabilities in global public finance.

Despite most countries having universal healthcare systems, access challenges remain. Differences between socio-economic groups are significant, with persons in the lowest-income quintile 2.5 times more likely to report unmet medical care needs than persons in the highest-income quintile.

This gradient matters economically as well as clinically. Lower-income populations carry higher burdens of chronic disease, are more likely to present late-stage, and have fewer resources to absorb the financial consequences of acute care. The cost of their deferred care falls heavily on public hospital systems, which are themselves under fiscal pressure to reduce expenditure. The result is a compounding spiral in which the populations most likely to skip care are the ones whose eventual acute presentations are most expensive to manage.

While challenges exist in quantifying return on investment for non-pharmaceutical interventions, the primary issue lies in the lack of visibility of the impact of prevention in health budgets, and the tendency to prioritise immediate treatment and cure rather than long-term prevention.

Australia: The Cost of a Narrowing Safety Net

Australia's Medicare system was designed to ensure that cost would not be a barrier to essential primary care. For decades, the bulk billing rate, the proportion of GP visits where the doctor accepts the Medicare rebate as full payment, served as the practical measure of that guarantee.

The bulk billing rate for GP visits fell from 88.8 percent to 77.3 percent over the three financial years from 2021-22 to 2023-24. Over the same period, total patient out-of-pocket costs more than doubled, from $780 million to $1.66 billion, and the proportion of people delaying or deferring GP care due to cost more than doubled, from 3.5 percent to 8.8 percent.

This is the cost of skipping healthcare made quantifiable at a national scale. A narrowing of access by 11.5 percentage points in the bulk billing rate produced a doubling of both out-of-pocket costs and the rate of deferred care, within three years, in a system with universal coverage, among a high-income population.

The Australian Government's $7.9 billion investment in expanded bulk billing incentives from November 2025 represents a direct response to this data. But as analysis published by Therapy Insights has examined, access barriers in Australia extend well beyond the GP consultation fee. The cost of living crisis and rising fuel prices are making healthcare inaccessible for many Australians, particularly those in regional areas, those dependent on transport to reach services, and those managing disability and chronic care needs across geographic distances that make even a subsidised visit financially prohibitive when transport costs are factored in.

The GP fee is only one component of the cost of a healthcare visit. The full cost, which includes transport, time off work, childcare, and any out-of-pocket costs for allied health or specialist follow-up, is often substantially higher than the gap fee alone. As fuel prices and living costs rise, the effective cost of accessing care rises with them, even when the headline rebate structure remains unchanged.

The Conclusion the Data Points To

The real cost of skipping one doctor visit is not the cost of the visit that was avoided. It is the cost of the condition that was not managed, compounded across the time between deferral and eventual presentation, and multiplied across every individual making the same calculation simultaneously.

Over 27 percent of ER visits could be avoided with timely and effective primary care, representing $32 billion in healthcare costs annually in the United States alone. That figure, for a single country, over a single year, illustrates the scale of the systemic inefficiency created by affordability barriers at the primary care level.

The global picture is proportionally larger, and the direction of travel is worsening. Cost-of-living pressures are tightening household budgets in every developed economy. Healthcare costs are rising faster than wages in most of them. The gap between what care costs and what households can absorb is widening, and the consequences are accumulating in the acute care settings that health systems can least afford to overload.

The question facing health systems is not whether the cost of skipping care is real. The data answers that question clearly: it is real, it is substantial, and it grows with every week of deferral.

The question is whether health systems are structured, and funded, to make the cheaper, earlier option genuinely accessible to everyone who needs it. The evidence suggests, consistently and globally, that many are not.

Understanding why, and what it will take to change that, is the work documented in our ongoing analysis of the global healthcare access crisis and its intersection with the economic pressures now reshaping healthcare decisions in every corner of the developed world.

About Author:
Joe Paradza is an Allied Health Leader and Healthcare Economics Analyst. He writes on healthcare economics, disability service delivery, and access policy for Therapy Insights, an independent Australian publication covering the forces shaping care delivery across Australia.

Related reading:
→ People Are Skipping Healthcare Because They Can't Afford It — A Global Crisis Is Emerging
→ What Happens When You Delay Medical Care? The Hidden Health Risks Most People Ignore
→ Cost of Living Crisis: Are Vulnerable Australians Losing Access to Care?